Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and...
markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(33)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Feb 14, 2024 1:37pm
RE:RE:New ceo please
Don't shout too loudly for a new ceo. You know the company, they always manage to surprise in a negative way. In the end it will be someone who previously had PRC Partners on their CV...
(72)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Feb 14, 2024 1:08pm
RE:New ceo please
I agree that a new CEO would be great, but it will not happen before sales cashflow has been established. Simply put - the company cannot afford it yet, but maybe in the autumn 2025. Therefore I hope
...more
(1558)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Feb 14, 2024 11:18am
Why is the share price at 9 cents?
The only reason I can come up with is that, with the delay in anything coming from the AbbVie/1067 "deal", it is making it look like another Rodan and Fields scam. Now that they are pumping
...more
(109)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Feb 14, 2024 10:35am
RE:New ceo please
I would presume the Sirona Laboratories subsidiary would have a new CEO attached to that organization. So we wait to see what they come up with re equity raise, and then essentially: 1067: this is
...more
(29)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Feb 14, 2024 9:46am
New ceo please
Now that you become a professionell company please change the ceo to bring the trust back to the shareholders. That is the only way to get a better shareprize
(1)
•••
can747
X
View Profile
View Bullboard History
Comment by
can747
on Feb 14, 2024 9:35am
RE:New video
For those on Facebook they did post it there on their page, so you can always post comments there.
(109)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Feb 14, 2024 9:08am
RE:RE:RE:RE:RE:RE:RE:RE:New video
I sent a few questions to the CFO the other day and asked about AbbVie's interest in 1326. His response was YES and that upcoming meetings were planned. Geraldine didn't say in her video who
...more
(109)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Feb 14, 2024 9:02am
RE:Comments on video
I certainly did. She is honest and balanced and hearing this from the CSO takes all the unnecessary rhetoric out of the communication and it's something larger investors would listen to.
(1558)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Feb 14, 2024 8:02am
New vidoe on twitter, finally
https://twitter.com/SironaBiochem/status/1757709077323399267 And there are more than a few people who check out their twitter posts. So maybe the word will get out despite the incompetence of
...more
(16)
•••
LakeOromocto
X
View Profile
View Bullboard History
Comment by
LakeOromocto
on Feb 14, 2024 12:27am
RE:RE:RE:RE:RE:RE:RE:New video
Thanks for the positive outlook and comments. My guess is AbbVie is still interested in anti aging. Remember AbbVie had input on the human trial. Our pushing forward heading to market might cause them
...more
(115)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Feb 14, 2024 12:20am
RE:RE:RE:RE:RE:RE:RE:New video
The video was pretty darn good for sure. At least we know what's behind the scenes and some timelines. That was a good post Forhand. We don't really want to gripe about
...more
(72)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Feb 13, 2024 11:56pm
RE:RE:RE:RE:RE:RE:New video
I'm not happy with the share price at all, but I've decided not to bash everything they come up with or spread bitterness when the needle doesn't move - it doesn't help my investment.
...more
(16)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Feb 13, 2024 10:16pm
Comments on video
Well did you investors like the video? Did you prefer Geraldine?
(109)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Feb 13, 2024 8:20pm
RE:RE:RE:New video
Not sure why they would touch on this. They have specifically left 1067 out as it's already spoken for and likely under the license agreement it's for Allergan AbbVie to speak to from now on..
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday